Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George T Stevenson

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Molecular Medicine (Cambridge, Mass.)|March 24, 2007
CD38 as a therapeutic targetGeorge T Stevenson
Leukemia Research|January 22, 2005
Is antibody therapy of tumor compromised by infusion-related reactions? A case for inhibiting the activity of cyclooxygenase-2George T Stevenson
Haematologica|October 2, 2014
Three major uncertainties in the antibody therapy of cancerGeorge T Stevenson
Blood|February 17, 2012
Follicular lymphoma and the immune system: from pathogenesis to antibody therapyFreda K Stevenson, George T Stevenson
Molecular Immunology|January 4, 2011
A standardized conversion of IgG antibody to bispecific form with inversely altered affinities for Fcγ-receptors II and IIIWeng S Leong, Karen-Anne Thomas, Claude H Chan, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Molecular Medicine (Cambridge, Mass.)|March 24, 2007
CD38 as a therapeutic targetGeorge T Stevenson
Leukemia Research|January 22, 2005
Is antibody therapy of tumor compromised by infusion-related reactions? A case for inhibiting the activity of cyclooxygenase-2George T Stevenson
Haematologica|October 2, 2014
Three major uncertainties in the antibody therapy of cancerGeorge T Stevenson
Blood|February 17, 2012
Follicular lymphoma and the immune system: from pathogenesis to antibody therapyFreda K Stevenson, George T Stevenson
Molecular Immunology|January 4, 2011
A standardized conversion of IgG antibody to bispecific form with inversely altered affinities for Fcγ-receptors II and IIIWeng S Leong, Karen-Anne Thomas, Claude H Chan, et al.
Pageof 1